News and updates from the Big4 Space for Big4 Alumni.
Sunday, January 8, 2017
Biopharmaceutical M&A expected to soar in 2017 as pricing pressures dim global revenue outlook
The EY report finds the industry's need to engage in M&A has become amplified as payers continue to push back forcefully on price increases for older ...
No comments:
Post a Comment